                                                                          Human Molecular Genetics, 2009, Vol. 18,  1                 97–104
                                                                          doi:10.1093/hmg/ddn320
                                                                          Advance Access published October 1, 2008


Deletion smn-1, Caenorhabditis elegans
ortholog spinal muscular atrophy
gene, results locomotor dysfunction reduced lifespan
Michael Briese1,{, Behrooz Esmaeili1,{, Sandrine Fraboulet1,2, Emma C. Burt1,
Stefanos Christodoulou1, Paula R. Towers1, Kay E. Davies1 David B. Sattelle1,
1
 MRC Functional Genomics Unit, Department Physiology Anatomy Genetics, University Oxford,
South Parks Road, Oxford OX1 3QX, UK 2Institut des Neurosciences Grenoble, Centre recherche Inserm
U836-UJF-CEA-CHU, Universite´ Joseph Fourier, Baˆtiment Edmond J. Safra, Domaine la Merci, 38706 La Tronche
Cedex, France

Received August 15, 2008; Revised Accepted September 29, 2008


Spinal muscular atrophy common genetic cause infant mortality characterized degener-
ation lower motor neurons leading muscle wasting. causative gene identified survival
motor neuron (SMN). invertebrate model organism Caenorhabditis elegans contains smn-1, ortholog human SMN. Caenorhabditis elegans smn-1 expressed various tissues including nervous body wall muscle, knockdown smn-1 RNA interference embryonic lethal. smn-1(ok355) deletion, removes smn-1 including translation start site, produces pleio-
tropic phenotype including late larval arrest, reduced lifespan, sterility impaired locomotion phar-
yngeal activity. Mutant nematodes develop late larval stages maternal contribution smn-1 gene
product allows study SMN-1 functions embryogenesis. Neuronal, muscle-directed,
expression smn-1 partially rescues smn-1(ok355) phenotype.  deletion mutant smn-1(ok355)
provides useful platform functional analysis invertebrate ortholog human SMN protein.




INTRODUCTION                                                              protein product (4,5).  SMN1, SMA-determining
                                                                          gene, produces length SMN protein exclusively,
Spinal muscular atrophy (SMA) autosomal recessive neu-              SMN2 acts disease modifier gene romuscular disorder, childhood-onset, characterized             small functional SMN produces (6,7). degeneration lower motor neurons anterior horn                  genetic defect underlying SMA spinal cord leading proximal muscle wasting.              shown reside SMN gene, important questions  common genetic cause infant mortality inci-           cerning disease etiology remain unresolved. SMN dence 1 10 000 live births (1,2). Childhood-onset            expressed widely outside nervous
SMA cases deletions survival motor neuron (SMN)               (3).  specific motor neuron defect seen gene located telomeric copy (SMN1) centromeric                 SMA explained purely terms expression
copy (SMN2) chromosome 5 inverted duplicated                     pattern SMN instead relate function (8).
region (3). Owing single C T transition exon 7,            Animal models SMA indispensable majority transcripts originating SMN2 alternatively           study physiologic roles SMN muscle cells spliced lacking exon 7, rise truncated, unstable            neurons dissection pathological events


    correspondence addressed. Tel: þ44 1865272145; Fax: þ44 1865282651; Email: david.sattelle@dpag.ox.ac.uk
†
    M.B. B.E. contributed equally work.

# 2008 Author(s) Open Access article distributed terms Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses nc/2.0/uk/) permits unrestricted non-commercial use, distribution, reproduction medium, provided original work properly cited.
 98     Human Molecular Genetics, 2009, Vol. 18,  1


leading SMA.  model organisms
deployed far possess ortholog SMN1
gene, progress limited lethality resulting complete loss SMN. circumvent difficulty,
various strategies developed. Expression human SMN2 Smn 2/2 null mice rescues embryonic                Figure 1. smn-1(ok355) deletion allele, showing smn-1
                                                                       exon 5 remains. Arrows indicate direction transcription, open-reading
lethality generates animals movement defect             frames depicted boxes. Scale bar: 500 bp.
motor neuron loss resembling severe SMA (9). zebrafish, reduction Smn levels using antisense morpholinos pro-              Caenorhabditis elegans wild-type animals progress duces motor axon defects truncations aberrant              larval stages (L1 L4) reaching adulthood. branching (10). Drosophila mutant containing mis-sense             striking phenotype smn-1(ok355) mutant mutation fly smn gene survives late larval stages         late larval arrest (Fig. 2), including defects gonadogenesis maternally contributed smn mRNA (11). mutant               germline differentiation (Fig. 3). Arrested smn-1(ok355)
exhibits reduced excitatory postsynaptic currents struc-           homozygotes pale loss intestinal pigmenta-
tural defects neuromuscular junctions absence             tion giving starved appearance. mean lifespan motor neuron loss.                                                     6.0 days post-L1 compared 19.9 days balanced
   C. elegans ortholog human SMN1 gene               smn-1(ok355)/hT2[qIs48] 17.7 days N2 wild-types
identified termed smn-1 (12). green fluorescent                  (Fig. 4).
protein (GFP) reporter construct contains length smn-1, upstream sequence produces fluorescence various
tissues including nervous body wall muscles,            smn-1(ok355) mutants defects motility
demonstrating widespread expression smn-1. Additionally,            pharyngeal pumping SMN-1 protein detected immunofluorescence              Following larval arrest, smn-1(ok355) nematodes display pro- zygotic stage onwards, indicating maternal contribution          gressive decline motility. measure locomotory activity protein mRNA. far, functions C.                quantified thrashing rate animals M9 buffer.
elegans smn-1 studied vivo RNA interference            early development, e. arrest, thrashing rate
(RNAi) induced injection double-stranded RNA pro-           smn-1(ok355) homozygotes similar balanced
duces knockdown effects tissues, including maternal tran-       smn-1(ok355)/hT2[qIs48] heterozygotes N2 wild-types
scripts, silencing neuronal genes efficient        (Fig. 5). Thrashing smn-1(ok355) animals progressively
(13). Targeting smn-1 RNAi gives rise severe develop-          declined completely ceased 5 days post-L1. mental defects embryonic lethality, limiting          contrast, locomotion smn-1(ok355)/hT2[qIs48] heterozygous
investigations postembryonic roles SMN-1 (12).              animals similar N2 wild-types time-points  characterized smn-1(ok355) deletion allele,                assay. removes smn-1 including translation start               Likewise, smn-1(ok355) mutants unable feed loss
codon, resulting late larval arrest, dramatic decrease life-   pharyngeal function. rate pharyngeal pumping span impaired locomotion pharyngeal pumping.            measured smn-1(ok355) homozygous mutants period
Early larval development smn-1(ok355) mutant animals                4 days compared N2 wild-type animals appears normal maternally contributed SMN-1.              smn-1(ok355)/hT2[qIs48] heterozygotes (Fig. 6). models aspects SMA, smn-1 mutant lends itself           day assay (1 day starved L1 larvae placed functional analysis SMN ortholog potential               seeded NGM plates), pharyngeal pumping rate future utilities screens searching phenotypic modifiers         mutant indistinguishable wild-type nematodes. step potential SMA therapies.                        Similar body wall muscle activity, pharyngeal pumping rates
                                                                       showed rapid progressive decline. Taken                                                                         data indicate general defect behaviors requiring rhythmic
RESULTS                                                                contractions muscle tissue smn-1(ok355) animals. smn-1(ok355) deletion
                                                                       Neuronal expression smn-1 partially rescues
Like model organisms studied date, C. elegans                                                                        smn-1(ok355) phenotype single copy gene encoding survival motor neuron
protein. smn-1(ok355) allele described removes                recently shown phenotype severe SMA
975 bp comprising 246 bp upstream intergenic region             mice corrected expressing length SMN solely smn-1 gene leaving 87 bp (including               nervous (14). investigate sensitivity stop codon) 30 end  exon 5; Fig. 1).            different aspects C. elegans neuromuscular coding sequences adjacent genes klp-16                      smn-1 loss, sought provide wild-type smn-1 F30A10.10 unaffected smn-1(ok355) deletion.                 muscles neurons smn-1(ok355) mutants. end, res-
Absence smn-1 ATG start codon remaining                  cuing constructs used expressing length smn-1 sequence suggests smn-1(ok355) null allele               body wall vulval muscles myo-3 promoter SMN-1 present maternal, originating             (Pmyo-3::smn-1) neurons unc-119 pro-
balanced smn-1(ok355)/hT2[qIs48] heterozygous mothers                  moter (Punc-119::smn-1). Promoters unc-119 myo-3
(strain LM99).                                                         used previously neuronal- muscle-directed
                                                                                         Human Molecular Genetics, 2009, Vol. 18,  1                       99




Figure 2. Developmental comparison smn-1(ok355) mutants, smn-1(ok355)/hT2[qIs48] heterozygotes N2 wild-type C. elegans. Age  days post-L1) indicated left. images depict representative phenotypic appearances synchronized animals given age. images anterior left posterior right.

rescue (15,16) considered strong transcriptional indu-                    starved.  did reach size fully-grown
cers (17). rescuing constructs microinjected                    adult smn-1(ok355)/hT2[qIs48] heterozygotes, indicating
gonads smn-1(ok355)/hT2[qIs48] heterozygotes generate                       partial opposed rescue. noted extent heritable lines. Transgenic heterozygous mothers carry                        rescuing effects variable  likely, reflects
plasmid DNA multi-copy, extrachromosomal arrays                            mitotic instability extrachromosomal transgene. transmit transgene certain frequency                            agreement body length measurements, neuronal-
progeny including smn-1(ok355) homozygotes. Extrachromo-                          expressing smn-1(ok355); Ex[Punc-119::smn-1] animals
somal transgenes frequently lost cell division result-                 survived longer smn-1(ok355) muscle-expressing
ing mosaic expression transgene (18).                                   smn-1(ok355); Ex[Pmyo-3::smn-1] animals (Fig. 7C)    Despite having injected large number animals,                        showed partial correction pharyngeal pumping heritable transgenic line obtained carrying                          defect (Fig. 6). Taken  data suggest extrachromosomal Ex[Pmyo-3::smn-1] Ex[Punc-119::smn-                           restoration neuronal smn-1 activity  partially,
1] unknown reasons. indicator transgene                      correct aspects smn-1(ok355) phenotype.
expression vivo, GFP fusions Pmyo-3::GFP Punc-119::GFP injected rescuing constructs
showed expression expected tissues (body wall                              nervous smn-1(ok355) animals vulval muscles Pmyo-3 nervous                              Having shown neuronal-directed expression smn-1 Punc-119, data shown).                                                        effective muscle-directed expression rescu-
   mutant smn-1(ok355) animals expressing muscle-                         ing larval arrest phenotype smn-1(ok355), sought directed smn-1 showed weak phenotypic rescue                            test smn-1(ok355) exhibits nervous abnor-
subset animals, pan-neuronal expression smn-1 produced                      malities general loss cholinergic motor neurons stronger rescue effects (Fig. 7A). Albeit remaining sterile,                      particular. end used pan-neuronal marker
rescued smn-1(ok355); Ex[Punc-119::smn-1] animals                             F25B3.3::GFP (19) (strain LM111) marker cholin- larger body size compared smn-1(ok355) smn-1                           ergic neurons unc-17::GFP (strain LM112) facilitate neur-
(ok355); Ex[Pmyo-3::smn-1] animals (Fig. 7B)                            onal identification. basis connectivity, motor
retained intestinal pigmentation, appearing                       neurons subdivided classes innervate dorsal
 100      Human Molecular Genetics, 2009, Vol. 18,  1




                                                                               Figure 4. Survival smn-1(ok355) mutants (n ¼ 58) comparison                                                                                smn-1(ok355)/hT2[qIs48] heterozygotes (n ¼ 56) N2 wild-type
                                                                               C. elegans (n ¼ 54). data point represents fraction synchronized
                                                                               animals alive given day.


                                                                               smn-1 RNAi (12), remains unlikely smn-1(ok355)
                                                                               deletion phenotype described caused combined
                                                                               loss smn-1 klp-16 function.
Figure 3. Gonad migration defects C. elegans smn-1(ok355) mutants.        smn-1(ok355) mutation essentially null allele, albeit
N2 wild-type hermaphrodites gonad folds L4 stage       retaining progressively decreasing levels maternal SMN-1.
develops U-shaped manner. (B) arrested smn-1(ok355) gonad          Immunofluorescence analysis embryos previously
fails develop properly.                                                     revealed presence SMN-1 cell stage (P0)
                                                                               prior initiation novo zygotic transcription (12). 
muscles sending axons dorsally commissures                      sidering RNAi-mediated knockdown smn-1, form dorsal nerve cord classes project ven-                 reduces levels maternal zygotic transcripts,
trally. Motor neurons (classes individual cells) identi-              leads embryonic lethality, postulate maternal 
fied studying axonal trajectories cell body position              tribution SMN-1 allows progression smn-1(ok355) dorsal/ventral nerve cord LM111 animals (20).                        animals early development. Consistent detect gross abnormalities nervous                         notion, thrashing rate smn-1(ok355) unaffected prior morphology smn-1(ok355); F25B3.3::GFP animals                        arrest, indicating normal functioning neuromuscular
(Fig. 8A). attempt test loss                       Presumably, progressive reduction maternal
neurons time, LM112 animals staged                           SMN-1 results developmental arrest homozygous
number cholinergic neurons ventral nerve cord                    animals late larval stage reflected defect gonadogen-
counted using marker unc-17::GFP labels embryonic                     esis followed paralysis early lethality. postembryonic motor neurons (21,22). differences                           Closer inspection ventral nerve cord neuronal detected number GFP-positive neurons                     GFP-expressing smn-1(ok355) animals failed reveal ventral cord region smn-1(ok355) smn-1(ok355)/                     loss cholinergic motor neurons. finding indicates hT2[qIs48] 5 days post-L1 (Fig. 8B).                                     embryonic postembryonic motor neuron development pro-
                                                                               ceeds normally sufficient levels maternally contri-
                                                                               buted SMN-1 prior larval arrest. absence                                                                                motility defect early larval stages underlines DISCUSSION
                                                                               notion  smn-1(ok355) animals, motor neurons initially animal models SMA studied date, ortholog                   establish normal functional connections target
human SMN ubiquitously expressed exists single-                    muscles. movement defects appeared, copy gene. shown  C. elegans                               detect loss cholinergic motor neurons smn-1(ok355) deletion mutant, loss SMN-1 protein                        ventral nerve cord. paralysis ensues, motor
leads progressive decline motor function.                         neuron numbers remain unaffected.  smn-1(ok355) coding regions neighboring genes remain                      mutants, maternally contributed SMN-1 sustain
intact, remains possible upstream regulatory                       development late larval stages animals arrest sequence klp-16 affected smn-1(ok355) del-                    response SMN protein depletion absence etion disrupting klp-16 expression                    obvious loss neuronal cell bodies.
klp-16(ok1505) mutant containing 1.1 kb deletion                     absence motor neuron loss smn-1(ok355) animals klp-16 coding sequence obvious defects, normal                     contrast mouse models SMA exhibiting motor defects
movement, body size brood size (data shown).                      accompanied motor neuron degeneration (9), zebrafish
taken finding smn-1(ok355) mutant                   SMA model showing axon path-finding defects response phenocopies affected progeny originating                         morpholino-induced smn knockdown (10).                                                                                  Human Molecular Genetics, 2009, Vol. 18,  1                  101




Figure 5. Progressive development movement defects C. elegans        Figure 6. Pharyngeal pumping analysis C. elegans smn-1(ok355) mutants,
smn-1(ok355) animals, balanced smn-1(ok355)/hT2[qIs48] heterozygotes   balanced smn-1(ok355)/hT2[qIs48] heterozygotes N2 wild-types N2 wild-type animals. group, n ¼ 20. Asterisks: P , 0.001.    muscle-expressing smn-1(ok355); Ex[Pmyo-3::smn-1] neuronal-
graphs depict mean + SEM.                                                  expressing smn-1(ok355); Ex[Punc-119::smn-1] animals. Asterisks: P ,
                                                                           0.0001. Numbers base bar indicate number animals used.
                                                                           graphs depict mean + SEM.
smn-1(ok355) phenotype described resembles Drosophila SMA model bearing mis-sense mutation smn                   neurons addressed rescue experiments similar mutations SMA patients (11).               smn-1 delivered locally muscle cells mutant smn flies survive past embryogenesis                neurons. emerged neuronal-directed, muscle-
maternally contributed mRNA die late larvae following               directed, expression smn-1 partially rescued depletion maternal component.  homo-                smn-1(ok355) phenotype. assessing rescue exper-
zygous smn mutant fly larvae produce mutant wild-                 iments, taken account,  type Smn protein presence transcripts,                  unc-119 promoter used exhibits pan-neuronal
smn-1(ok355) larvae contain wild-type smn-1 transcript.               activity exclude possibility promoter activity  smn-1(ok355) mutant relates               levels detection limit cell types vast majority SMA cases showing deletions                    neurons. Furthermore, rule possibility SMN1 gene, situation nematode model SMA                     structure composition extrachromosomal
differs SMA facets. Caenorhabditis elegans                 arrays different producing variability produces length SMN-1 protein gene                      extent mosaicism transgene expression levels.
encoding SMN ortholog, smn-1. contrast, addition                  light findings, note neur-
SMN1, humans possess SMN2 SMA patients acts                       onal expression length human SMN Prion protein phenotypic modifier gene producing low levels func-                (PrP) promoter rescues severe SMA mice containing tional SMN protein. consequence, SMA caused                     copies human SMN2 lacking mouse Smn (Smn 2/2 ;
insufficiency complete loss SMN protein. Fur-             SMN2 þ/þ ) (14). SMA mice normally average
thermore, unlike case C. elegans Drosophila,             lifespan 5 days (9), extended 210 days maternal contribution SMN mRNA mammals.                    line homozygous PrP-SMN transgene
example, homozygous loss Smn mice embryonic                       (Smn 2/2 ; SMN2 þ/þ ; PrP-SMN). SMN targeted
lethal (23), overcome expressing human                   skeletal muscle using human skeletal actin
SMN2 Smn 2/2 mice (9,24).  absence C.                     (HSA) promoter improvement SMA phenotype
elegans SMN2 ortholog combined maternally contributed                 extension survival seen. HSA – SMN line
SMN-1 causes smn-1(ok355) mutants exhibit gradual                     showing low expression SMN spinal cord did
decline SMN-1 levels ultimately leading complete                   affect SMA phenotype mice living 160 days loss protein opposed low remaining SMN                    average.  small increase SMN neurons suf-
levels seen SMA patients.                      ficient extend survival SMA mice considerably
maternal transmission mask possible functions                       high SMN levels mature skeletal muscle SMN-1 development, smn-1(ok355) mutant pro-                     effect. comparison data observed vides opportunity study postembryonic roles                      partial opposed rescue expressing smn-1 SMN-1 motor neurons neuromuscular junctions.                     nervous smn-1(ok355) animals. difference
   understand pathological events leading                explained complete loss maternally 
SMA, critical elucidate SMN reduction                 tributed SMN-1 activity non-neuronal tissues motor neurons primary defect disease                     rescued smn-1(ok355); Ex[Punc-119::smn-1] animals  independent muscle defects                       trast low remaining levels rescued Smn 2/2 ; answer question particularly important              SMN2 þ/þ ; PrP-SMN mice.
development therapeutic strategies aiming regulate                   conclusion, C. elegans mutant smn-1(ok355) provides SMN levels selected cell types.                         disease model mimicking aspects SMA reduced
smn-1(ok355) phenotype originates defects muscles                SMN-1 protein levels organism. Mutant
 102       Human Molecular Genetics, 2009, Vol. 18,  1




Figure 7. Neuronally expressed smn-1 partially rescues C. elegans smn-1(ok355) phenotype.   Examples mutant animals carrying extrachromosomal
Pmyo-3::smn-1 inducing expression smn-1 body wall vulval muscles Punc-119::smn-1 smn-1 expression neurons. comparison, arrested
smn-1(ok355) adult smn-1(ok355)/hT2[qIs48] animals shown. (B) Comparison body lengths arrested smn-1(ok355), adult smn-1(ok355)/hT2[qIs48] fully-grown smn-1(ok355); Ex[Pmyo-3::smn-1] smn-1(ok355); Ex[Punc-119::smn-1] animals. Graphs median, n ¼ 100 group.
Asterisks: P , 0.001. (C) Survival smn-1(ok355); Ex[Pmyo-3::smn-1] (n ¼ 26) smn-1(ok355); Ex[Punc-119::smn-1] (n ¼ 24) animals comparison smn-1(ok355)/hT2[qIs48] heterozygotes (n ¼ 30) smn-1(ok355) homozygotes (n ¼ 15, data taken independent experiment). Scale bar  : 200 mm.


animals proceed embryogenesis arrest late larvae                [bli-4(e937) let-?(q782) qIs48]  III); mdEx72] VC1005
indicating  C. elegans, SMN-1 functions later               [klp-16(ok1505) .
development adult life. future studies, smn-1(ok355)
mutants serve starting point identification modifier genes genetic genome-wide RNAi screens                     Isolation smn-1(ok355) deletion
enhance suppress smn-1(ok355) phenotype devel-                  smn-1(ok355) deletion allele smn-1 located chromo-
oping novel therapeutic strategies drug screens.                            obtained C. elegans Gene Knockout 
                                                                               sortium. genetically heterogeneous population,                                                                                cloned individual animals heterozygous deletion MATERIALS METHODS                                                          crossed times wild-type (N2) nematodes.
                                                                               unbalanced smn-1(ok355)/þ strain (LM97) main-
Strains                                                                        tained picking heterozygous animals confirming
Strains grown maintained described previously                      presence deletion PCR using primers
(25). following strains used study: N2,                       50 -GACTTCAGATTTGATCAACGGTC-30 50 -ACACCA
NW1229 [evIs111[F25B3.3::GFP; dpy-20(þ)]], RM1872                              ATTACCAAACGATCAAC-30 . Stable maintenance [mdEx72[unc-17::GFP; pha-1(þ)]], LM97 [smn-1(ok355)/þ ,                      deletion achieved introducing genetic balancer
LM99 [smn-1(ok355) hT2[bli-4(e937) let-?(q782) qIs48]                        hT2  III), reciprocal translocation chromosomal
 III)], LM111 [smn-1(ok355) hT2[bli-4(e937) let-?(q782)                    segments chromosomes III, generating strain
qIs48]  III); evIs111], LM112 [smn-1(ok355) hT2                            LM99. distinguish homozygous heterozygous
                                                                                 Human Molecular Genetics, 2009, Vol. 18,  1                  103




Figure 8. nervous C. elegans smn-1(ok355) animals.   Arrangement nerve cell bodies ventral nerve cord L3 smn-1(ok355)/
hT2[qIs48] heterozygotes smn-1(ok355) homozygotes. F25B3.3::GFP labels neuron types unc-17::GFP restricted cholinergic neurons.
(B) Cholinergic motor neuron number ventral nerve cord smn-1(ok355) smn-1(ok355)/hT2[qIs48] animals. GFP-positive neurons expressing cholinergic marker unc-17::GFP counted including VA2 (anterior) VA11 neuron (posterior). group, n ¼ 10. graphs depict mean + SEM.


animals visually, used hT2[bli-4(e937) let-?(q782)                   Lifespan brood size assays
qIs48]  III) derivative chromosomal balancer,                lifespan assay synchronized smn-1(ok355) homo-
qIs48 insertion extrachromosomal ccEx9747 carrying                 zygotes, smn-1(ok355)/hT2[qIs48] heterozygotes N2 promoter::GFP fusions myo-2::GFP (expressed                      wild-types aged 1 day post-L1 placed OP50-seeded
pharynx), pes-10::GFP (expressed 4 – 60 cell embryos)                    plates (5 cm diameter) 228C. Survival monitored gut-specific enhancer fused GFP (26,27). Hetero-                   daily, animals scored dead longer
zygous smn-1(ok355) hT2[bli-4(e937) let-?(q782) qIs48]                    responded head tail touch using platinum wire pick.
 III) (referred ‘smn-1(ok355)/hT2[qIs48]’) segregate
                                                                            avoid crowding progeny production ensure
smn-1(ok355) homozygotes, hT2[qIs48] homozygotes,
                                                                            availability sufficient food, animals transferred
smn-1(ok355)/hT2[qIs48] heterozygotes arrested aneu-
                                                                            new plates deemed necessary. Animals crawled
ploid progeny. hT2[qIs48] homozygous lethal,                                                                             NGM agar excluded data. brood
animals expressing GFP heterozygous smn-1(ok355).
                                                                            size assays, klp-16(ok1505) wild-type N2 animals Animals homozygous smn-1(ok355) deletion                                                                             synchronized brood size determined 5 day
identified absence GFP fluorescence pharynx.               period post-L4 208C. PCR analysis used confirm
                                                                            presence klp-16(ok1505) deletion using primers
                                                                            recommended WormBase (http://www.wormbase.org/).
Physiological assays
Embryos released subjecting gravid N2 LM99
                                                                            Tissue-specific rescue smn-1(ok355) mutant
hermaphrodites bleach subsequently left M9
overnight obtaining hatched synchronized smn-1(ok355)                   rescue smn-1(ok355) phenotype tissue-specific
homozygotes, balanced smn-1(ok355)/hT2[qIs48] heterozy-                     manner, smn-1(ok355)/hT2[qIs48] heterozygotes gotes N2 wild-types L1 larval stage. Synchronized                microinjected promoter::smn-1 fusion constructs
L1 larvae placed nematode growth medium (NGM)                       Pmyo-3::smn-1 Punc-119::smn-1 expressing smn-1 plates seeded E. coli OP50, left 1 day 228C.                body wall muscle neuronal tissue, respectively. res-
Motility assessed day placing animals                  cuing constructs contain smn-1 ATG start M9 buffer measuring movement thrashing rate                    TAA stop codon (amplified N2 genomic DNA) placed 1 min period. single thrash defined change                  transcriptional control 2 kb upstream myo-3 direction bending mid-body. Animals                   Pmyo-3::smn-1 (generating muscle-directed expression) left M9 5 min prior measurement. quanti-             2.2 kb upstream unc-119 Punc-119::smn-1  pan-
fication pharyngeal pumping synchronized smn-1(ok355)                    neuronal expression). visualize promoter activity, smn-1
homozygotes, smn-1(ok355)/hT2[qIs48] heterozygotes, N2                      replaced GFP generate reporters
wild-type tissue-specific rescue animals                      Punc-119::GFP Pmyo-3::GFP. neuronal rescue,
aged 1 day post-L1 placed OP50-seeded plates                     Punc-119::smn-1 Punc-119::GFP injected 228C. Terminal bulb pumps measured day                      10 ng/ml pRF4 200 ng/ml encoding dissection microscope periods 15 s. 2                  marker rol-6(su1006) expression induces 10 periods 15 s counted animal.                            ‘rolling’ phenotype (28). Analogously, muscle-directed
 104      Human Molecular Genetics, 2009, Vol. 18,  1


rescue attempts, Pmyo-3::smn-1 injected                                     human centromeric survival motor neuron gene (SMN2) rescues
Pmyo-3::GFP pRF4.                                                                   embryonic lethality Smn(2/2) mice results mouse spinal
                                                                                        muscular atrophy. Hum. Mol. Genet., 9, 333–339.
   body length measurements, photomicrographs                            10.   McWhorter, M.L., Monani, U.R., Burghes, H. Beattie, C.E. (2003)
taken mobile growth-arrested smn-1(ok355) animals,                               Knockdown survival motor neuron (Smn) protein zebrafish identified starved, pale appearance,                            causes defects motor axon outgrowth pathfinding. J. Cell Biol., 162,
adult smn-1(ok355)/hT2[qIs48] animals mixed-stage                                  919–931.
populations. body length analysis transgenic rescue                        11.   Chan, Y.B., Miguel-Aliaga, , Franks, C., Thomas, N., Trulzsch, B.,
nematodes, individual animals monitored daily                                 Sattelle, D.B., Davies, K.E. van den Heuvel, M. (2003)
                                                                                        Neuromuscular defects Drosophila survival motor neuron gene
deemed necessary variability extent rescue                             mutant. Hum. Mol. Genet., 12, 1367– 1376.
observed. Photomicrographs transgenic rescue animals                           12.   Miguel-Aliaga, , Culetto, E., Walker, D.S., Baylis, H , Sattelle, D.B. taken considered fully grown                              Davies, K.E. (1999) Caenorhabditis elegans orthologue appeared starved, e. growth-arrested, immobile.                          human gene responsible spinal muscular atrophy maternal product
Images animals obtained using Nikon SMZ1000                                   critical germline maturation embryonic viability. Hum. Mol.
                                                                                        Genet., 8, 2133–2143.
stereomicroscope analyzed using ImageJ software                          13.   Timmons, L., Court, D.L.   (2001) Ingestion bacterially
NIH (http://rsb.info.nih.gov/ij/) measure body length                            expressed dsRNAs produce specific potent genetic interference midline tip head base                           Caenorhabditis elegans. Gene, 263, 103–112.
tail. Lifespan rescue animals assessed picking syn-                     14.   Gavrilina, T.O., McGovern, V.L., Workman, E., Crawford, T.O.,
chronized animals aged 3 days post-L1 monitoring                              Gogliotti, R.G., DiDonato, C.J., Monani, U.R., Morris, G.E. Burghes,
survival described                                                             H. (2008) Neuronal SMN expression corrects spinal muscular atrophy
                                                                                        severe SMA mice muscle-specific SMN expression                                                                                         phenotypic effect. Hum. Mol. Genet., 17, 1063– 1075.
                                                                                  15.   Feng, , Li, W., Ward, , Piggott, B.J., Larkspur, E.R., Sternberg, P.W.
FUNDING                                                                                 Xu, X  (2006) C. elegans model nicotine-dependent behavior: work funded Medical Research Council                                 regulation TRP-family channels. Cell, 127, 621–633.
                                                                                  16.   Wolkow, C , Kimura, K.D., Lee, M.S. Ruvkun, G. (2000) UK. M.B. supported Wellcome Trust 4-Year                                   Regulation C. elegans life-span insulinlike signaling nervous
Doctoral Programme Neuroscience.                                                      Science, 290, 147–150.
                                                                                  17.   Timmons, L., Tabara, H., Mello, C.C.   (2003) Inducible
                                                                                        systemic RNA silencing Caenorhabditis elegans. Mol. Biol. Cell, 14,
ACKNOWLEDGEMENTS                                                                        2972– 2983.
                                                                                  18.   Stinchcomb, D.T., Shaw, J.E., Carr, S.H. Hirsh, D. (1985) authors like thank C. elegans Gene Knockout                            Extrachromosomal DNA transformation Caenorhabditis elegans. Mol.
Consortium Caenorhabditis Genetics Center pro-                              Cell Biol., 5, 3484–3496.
viding strains.                                                                   19.   Altun-Gultekin, , Andachi, Y., Tsalik, E.L., Pilgrim, D., Kohara, Y.                                                                                         Hobert, O. (2001) regulatory cascade homeobox genes, ceh-10,
Conflict statement. declared.                                          ttx-3 ceh-23, controls cell fate specification defined interneuron
                                                                                        class C. elegans. Development, 128, 1951–1969.
                                                                                  20.   White, J.G., Southgate, E., Thomson, J.N. Brenner, S. (1986)                                                                                         structure nervous nematode Caenorhabditis elegans.
REFERENCES                                                                              Philos. Trans. R. Soc. Lond. B Biol. Sci., 314, 1– 340.
1. Roberts, D.F., Chavez, J. Court, S.D. (1970) genetic component         21.   Lickteig, K.M., Duerr, J.S., Frisby, D.L., Hall, D.H., Rand, J.B.    child mortality. Arch. Dis. Child., 45, 33– 38.                                   Miller, D.M. III (2001) Regulation neurotransmitter vesicles 2. Ogino, S. Wilson, R.B. (2002) Genetic testing risk assessment            homeodomain protein UNC-4 transcriptional corepressor UNC-37/
   spinal muscular atrophy (SMA). Hum. Genet., 111, 477–500.                            groucho Caenorhabditis elegans cholinergic motor neurons.
3. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet,         J. Neurosci, 21, 2001–2014.
   L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995)        22.   Rand, J.B., Duerr, J.S. Frisby, D.L. (2000) Neurogenetics vesicular
   Identification characterization spinal muscular                             transporters C. elegans. FASEB J, 14, 2414– 2422.
   atrophy-determining gene. Cell, 80, 155– 165.                                  23.   Schrank, B., Gotz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith,
4. Lorson, C.L. Androphy, E.J. (2000) exonic enhancer required                G. Sendtner, M. (1997) Inactivation survival motor neuron
   inclusion essential exon SMA-determining gene, SMN.                 gene, candidate gene human spinal muscular atrophy, leads    Hum. Mol. Genet., 9, 259– 265.                                                       massive cell death early mouse embryos. Proc. Natl Acad. Sci. USA, 94,
5. Vitte, J., Fassier, C., Tiziano, F.D., Dalard, C., Soave, S., Roblot, N.,            9920– 9925.
   Brahe, C., Saugier-Veber, P., Bonnefont, J.P. Melki, J. (2007) Refined     24.   Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai,
   characterization expression stability SMN gene products.           C.H. Li, H. (2000) mouse model spinal muscular atrophy. Nat.
    J. Pathol., 171, 1269–1280.                                                      Genet., 24, 66–70.
6. Lorson, C.L., Hahnen, E., Androphy, E.J. Wirth, B. (1999) single
                                                                                  25.   Brenner, S. (1974) genetics Caenorhabditis elegans. Genetics, 77,
   nucleotide SMN gene regulates splicing responsible                                                                                         71– 94.
   spinal muscular atrophy. Proc. Natl Acad. Sci. USA, 96, 6307–